Literature DB >> 11169450

Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells.

A Wack1, E Soldaini, C Tseng, S Nuti, G Klimpel, S Abrignani.   

Abstract

Chronic hepatitis C virus (HCV) infection frequently develops into liver disease and is accompanied by extra-hepatic autoimmune manifestations. The tetraspanin CD81 is a putative HCV receptor as it binds the E2 envelope glycoprotein of HCV and bona fide HCV particles. Here we show that HCV E2 binding to CD81 on human cells in vitro lowers the threshold for IL-2 receptor alpha expression and IL-2 production, resulting in strongly increased T cell proliferation. HCV E2-induced co-stimulation also enhances the production of IFN-gamma and IL-4 and causes increased TCR down-regulation. This suggests that binding of HCV particles to CD81 on T cells in vivo may lead to activation by otherwise suboptimal stimuli. Therefore, co-stimulation of autoreactive T cells by HCV may contribute to liver damage and autoimmune phenomena observed in HCV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11169450     DOI: 10.1002/1521-4141(200101)31:1<166::aid-immu166>3.0.co;2-l

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  51 in total

1.  EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells.

Authors:  Stéphanie Charrin; François Le Naour; Valérie Labas; Martine Billard; Jean-Pierre Le Caer; Jean-François Emile; Marie-Anne Petit; Claude Boucheix; Eric Rubinstein
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

2.  Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81.

Authors:  Heidi E Drummer; Kirilee A Wilson; Pantelis Poumbourios
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Complementary costimulation of human T-cell subpopulations by cluster of differentiation 28 (CD28) and CD81.

Authors:  Yael Sagi; Angela Landrigan; Ronald Levy; Shoshana Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

4.  Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding.

Authors:  Kathleen McCaffrey; Irene Boo; Pantelis Poumbourios; Heidi E Drummer
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

5.  Multimeric HCV E2 protein obtained from Pichia pastoris cells induces a strong immune response in mice.

Authors:  Gillian Martínez-Donato; Yanelis Capdesuñer; Nelson Acosta-Rivero; Armando Rodríguez; Juan Morales-Grillo; Eduardo Martínez; Marleny González; Julio C Alvarez-Obregon; Santiago Dueñas-Carrera
Journal:  Mol Biotechnol       Date:  2007-03       Impact factor: 2.695

Review 6.  Viral modulation of T-cell receptor signaling.

Authors:  Keith R Jerome
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

7.  Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.

Authors:  Xiping Zhao; Zhen-Ya Tang; Bettina Klumpp; Guido Wolff-Vorbeck; Heidi Barth; Shoshana Levy; Fritz von Weizsäcker; Hubert E Blum; Thomas F Baumert
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

8.  CD81-dependent binding of hepatitis C virus E1E2 heterodimers.

Authors:  Laurence Cocquerel; Chiung-Chi Kuo; Jean Dubuisson; Shoshana Levy
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 9.  Interferon alpha treatment and thyroid dysfunction.

Authors:  Yaron Tomer; Jason T Blackard; Nagako Akeno
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

Review 10.  The hepatitis C virus persistence: how to evade the immune system?

Authors:  Nicole Pavio; Michael M C Lai
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.